Literature DB >> 14526201

High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML.

Manuel Favre1, Christophe Butticaz, Brian Stevenson, C Victor Jongeneel, Amalio Telenti.   

Abstract

Alternative splicing may generate splice forms with different biologic roles or missing protein domains implicated in the interaction with HIV-1. To address this issue, 6 human genes were investigated-tumor suppressor gene 101 (TSG101), beta-transducin repeats containing protein (betaTrCP), peptidyl-proly cis-trans isomerase, cyclophilin A (PPIA), integrase interactor 1 protein (INI1), Nef-associated factor 1 (NAF1), and promyelacytic leukemia (PML)-involved in the viral life cycle and HIV-1 pathogenesis. All 6 genes presented alternative splicing, and a combined bioinformatic and reverse transcription polymerase chain reaction (RT-PCR) analysis identified 27 new variants for a total of 53 splice forms (an average of 9 variants per gene). The predicted frequency of the various splice forms based on expressed sequence tags (EST) analysis corresponded to the semiquantitative findings on RT-PCR analysis for the cell culture systems and for native CD4 cells investigated. Interindividual variation in the frequencies of various splice forms in CD4 T cells from blood donors was observed for INI1. Cell type-specific variation of splice pattern was observed for NAF1. Eight splice forms lacked or modified motifs implicated in the interaction with HIV-1, underscoring the potential interest of assessing alternative splicing when investigating viral cell biology and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526201     DOI: 10.1097/00126334-200310010-00002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

1.  PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Authors:  Igor Gurevich; Carmen Zhang; Priscilla C Encarnacao; Charles P Struzynski; Sarah E Livings; Brian J Aneskievich
Journal:  Biochim Biophys Acta       Date:  2011-10-07

2.  Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression.

Authors:  Gabriela Bleiber; Margaret May; Raquel Martinez; Pascal Meylan; Jürg Ott; Jacques S Beckmann; Amalio Telenti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  TNIP1 is a corepressor of agonist-bound PPARs.

Authors:  Anthony M Flores; Igor Gurevich; Carmen Zhang; Vincent P Ramirez; Taylor R Devens; Brian J Aneskievich
Journal:  Arch Biochem Biophys       Date:  2011-09-22       Impact factor: 4.013

Review 4.  A20-Binding Inhibitor of NF-κB Activation 1 is a Physiologic Inhibitor of NF-κB: A Molecular Switch for Inflammation and Autoimmunity.

Authors:  Rachel T G'Sell; Patrick M Gaffney; David W Powell
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

Review 5.  Emerging roles for TNIP1 in regulating post-receptor signaling.

Authors:  Vincent P Ramirez; Igor Gurevich; Brian J Aneskievich
Journal:  Cytokine Growth Factor Rev       Date:  2012-04-28       Impact factor: 7.638

6.  RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.

Authors:  German Melean; Ana Velasco; Elisabete Hernández-Imaz; Francisco Javier Rodríguez-Álvarez; Yolanda Martín; Ana Valero; Concepción Hernández-Chico
Journal:  Neurogenetics       Date:  2012-07-01       Impact factor: 2.660

7.  Elucidating role of salivary proteins in denture stomatitis using a proteomic approach.

Authors:  Sompop Bencharit; Sandra K Altarawneh; Sarah Schwartz Baxter; Jim Carlson; Gary F Ross; Michael B Border; C Russell Mack; Warren C Byrd; Christopher F Dibble; Silvana Barros; Zvi Loewy; Steven Offenbacher
Journal:  Mol Biosyst       Date:  2012-10-30

8.  Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome.

Authors:  A C J Ammerlaan; A Ararou; M P W A Houben; F Baas; C C Tijssen; J L J M Teepen; P Wesseling; T J M Hulsebos
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.